Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
Tempus AI, Inc. (NASDAQ: TEM), a technology firm at the forefront of using AI to enhance precision medicine, revealed that 37 abstracts will be showcased at the 2026 American Society of Clinical Oncology (ASCO®) Annual Meeting in Chicago, Illinois from May 29 to June 3, 2026. This strong presence signifies a notable achievement for Tempus, with this year's meeting featuring the largest number of accepted research presentations in the company's history.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments